Improving outcomes of acute kidney injury using mouse renal progenitor cells alone or in combination with erythropoietin or suramin

Stem Cell Research and Therapy

Volumn 4, Issue 3, 2013, Pages

  Han, Xiao ^a   Zhao, Li ^a   Lu, Guodong ^a   Ge, Junke ^a   Zhao, Yalin ^b   Zu, Shulu ^a   Yuan, Mingzhen ^a   Liu, Yuqiang ^a   Kong, Feng ^a   Xiao, Zhiying ^a   Zhao, Shengtian ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF OREGON   (United States)

Author keywords

Adult kidney stem cell; Cell therapy; Erythropoietin; Suramin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; CREATININE; ERYTHROPOIETIN; GREEN FLUORESCENT PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL ANTIGEN 1; SURAMIN; TRANSCRIPTION FACTOR PAX2; UREA; UVOMORULIN; VIMENTIN; ANTIANEMIC AGENT; CADHERIN; PAX2 PROTEIN, MOUSE; POU5F1 PROTEIN, MOUSE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ACUTE KIDNEY FAILURE; ADIPOCYTE; ADULT STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; IN VITRO STUDY; KIDNEY NECROSIS; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RENAL PROGENITOR CELL; STEM CELL TRANSPLANTATION; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG COMBINATION; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; TRANSPLANTATION;

MUS;

ACUTE KIDNEY INJURY; ADULT STEM CELLS; ANIMALS; ANTIGENS, CD34; CADHERINS; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; GREEN FLUORESCENT PROTEINS; HEMATINICS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OCTAMER TRANSCRIPTION FACTOR-3; PAX2 TRANSCRIPTION FACTOR; RECOMBINANT PROTEINS; SURAMIN; VIMENTIN;

EID: 84879060726     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt225     Document Type: Article

References (42)

1. Acute renal failure. Thadhani R, Pascual M, Bonventre JV, N Engl J Med 1996 334 1448 1460 10.1056/NEJM199605303342207 8618585 (Pubitemid 26157442)
2. Mechanisms of ischemic acute renal failure. Bonventre JV, Kidney Int 1993 43 1160 1178 10.1038/ki.1993.163 8510397 (Pubitemid 23137105)
3. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ, J Am Soc Nephrol 2006 17 1135 1142 10.1681/ASN.2005060668 16495381
4. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G, J Am Soc Nephrol 2009 20 1053 1067 10.1681/ASN.2008070798 19389847
5. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, Rambaldi A, Remuzzi A, Remuzzi G, Stem Cells 2008 26 2075 2082 10.1634/stemcells.2007-0795 18499895
6. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C, Am J Renal Physiol 2007 292 1626 1635 10.1152/ajprenal.00339.2006 (Pubitemid 46701891)
7. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria Avancini Costa Malheiros D, Antonia Dos Reis M, Shimizu MH, Seguro AC, Pacheco-Silva A, Saraiva Camara N, Stem Cells 2009 27 3063 3073 19750536
8. Isolation and characterization of kidney-derived stem cells. Gupta S, Verfaillie C, Chmielewski D, Kren S, Eidman K, Connaire J, Heremans Y, Lund T, Blackstad M, Jiang Y, Luttun A, Rosenberg ME, J Am Soc Nephrol 2006 17 3028 3040 10.1681/ASN.2006030275 16988061 (Pubitemid 44707763)
9. In search of adult renal stem cells. Anglani F, Forino M, Del Prete D, Tosetto E, Torregrossa R, D'Angelo A, J Cell Mol Med 2004 8 474 487 10.1111/j.1582-4934.2004.tb00472.x 15601576 (Pubitemid 44145480)
10. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Hauser PV, De Fazio R, Bruno S, Sdei S, Grange C, Bussolati B, Benedetto C, Camussi G, Am J Pathol 2010 177 2011 2021 10.2353/ajpath.2010. 091245 20724594
11. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, Abbate M, Zoja C, Cassis P, Longaretti L, Rebulla P, Introna M, Capelli C, Benigni A, Remuzzi G, Lazzari L, Stem Cells 2010 28 513 522 20049901
12. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M, Gesualdo L, Francini F, Maggi E, Annunziato F, Lasagni L, Serio M, Romagnani S, Romagnani P, J Am Soc Nephrol 2006 17 2443 2456 10.1681/ASN.2006010089 16885410 (Pubitemid 44300960)
13. Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. Maeshima A, Sakurai H, Nigam SK, J Am Soc Nephrol 2006 17 188 198 16338966
14. Generation of tubular superstructures by piling of renal stem/progenitor cells. Minuth WW, Denk L, Castrop H, Tissue Eng Part C Methods 2008 14 3 13 18454641 (Pubitemid 351520451)
15. Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury. Lee PT, Lin HH, Jiang ST, Lu PJ, Chou KJ, Fang HC, Chiou YY, Tang MJ, Stem Cells 2010 28 573 584 20099318
16. Nonerythropoietic properties of erythropoietin: implication for tissue protection. Rathod DB, Salahudeen AK, J Invest Med 2011 59 1083 1085
17. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C, Park KH, Han S, Kim JH, Na KY, Am J Nephrol 2009 30 253 260 10.1159/000223229 19494484
18. Erythropoietin prevents sepsis-related acute kidney injury in rats by inhibiting NF-κB and upregulating endothelial nitric oxide synthase. Souza AC, Volpini RA, Shimizu MH, Sanches TR, Camara NO, Semedo P, Rodrigues CE, Seguro AC, Andrade L, Am J Physiol Renal Physiol 2012 15 1045 1054
19. Suramin promotes recovery from renal ischemia/reperfusion injury in mice. Zhuang S, Lu B, Daubert RA, Chavin KD, Wang L, Schnellmann RG, Kidney Int 2009 75 304 311 10.1038/ki.2008.506 18843260
20. Recovery from glycerol-induced acute kidney injury is accelerated by suramin. Korrapati MC, Shaner BE, Schnellmann RG, J Pharmacol Exp Ther 2012 341 126 136 10.1124/jpet.111.190249 22228809
21. Isolation of renal progenitor cells from adult human kidney. Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, Camussi G, Am J Pathol 2005 166 545 555 10.1016/S0002-9440(10)62276-6 15681837 (Pubitemid 40189050)
22. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814 (Pubitemid 29282067)
23. An experimental model for assessment of renal recovery from warm ischemia. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J, Transplantation 1983 35 198 204 10.1097/00007890-198303000-00002 6340272 (Pubitemid 13113785)
24. Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. Dekel B, Zangi L, Shezen E, Reich-Zeliger S, Eventov-Friedman S, Katchman H, Jacob-Hirsch J, Amariglio N, Rechavi G, Margalit R, Reisner Y, J Am Soc Nephrol 2006 17 3300 3314 10.1681/ASN.2005020195 17093069 (Pubitemid 44865273)
25. Musculin/MyoR is expressed in kidney side population cells and can regulate their function. Hishikawa K, Marumo T, Miura S, Nakanishi A, Matsuzaki Y, Shibata K, Ichiyanagi T, Kohike H, Komori T, Takahashi I, Takase O, Imai N, Yoshikawa M, Inowa T, Hayashi M, Nakaki T, Nakauchi H, Okano H, Fujita T, J Cell Biol 2005 169 921 928 10.1083/jcb.200412167 15967813 (Pubitemid 41002868)
26. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Chen J, Park HC, Addabbo F, Ni J, Pelger E, Li H, Plotkin M, Goligorsky MS, Kidney Int 2008 74 879 889 10.1038/ki.2008.304 18596729
27. Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. Kitamura S, Yamasaki Y, Kinomura M, Sugaya T, Sugiyama H, Maeshima Y, Makino H, FASEB J 2005 19 1789 1797 10.1096/fj.05-3942com 16260649 (Pubitemid 41598763)
28. The renal papilla is a niche for adult kidney stem cells. Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q, J Clin Invest 2004 114 795 804 15372103 (Pubitemid 39578738)
29. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. Vigneau C, Polgar K, Striker G, Elliott J, Hyink D, Weber O, Fehling HJ, Keller G, Burrow C, Wilson P, J Am Soc Nephrol 2007 18 1709 1720 10.1681/ASN.2006101078 17475814 (Pubitemid 46870308)
30. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, Angelotti ML, Parente E, Mancina R, Netti GS, Becherucci F, Gacci M, Carini M, Gesualdo L, Rotondi M, Maggi E, Lasagni L, Serio M, Romagnani S, Romagnani P, J Exp Med 2008 205 479 490 10.1084/jem.20071903 18268039 (Pubitemid 351281611)
31. The expression of EPOR in renal cortex during postnatal development. Xiao L, Li Z, Xu P, Li Z, Xu J, Yang Z, PLoS One 2012 7 41993 10.1371/journal.pone. 0041993 22844537
32. Unexpected renal actions of erythropoietin. Westenfelder C, Exp Nephrol 2002 10 294 298 10.1159/000065304 12381912 (Pubitemid 36151243)
33. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Westenfelder C, Biddle DL, Baranowski RL, Kidney Int 1999 55 808 820 10.1046/j.1523-1755.1999.055003808.x 10027918 (Pubitemid 29100693)
34. Recombinant human erythropoietin attenuates renal tubulointerstitial injury in murine adriamycin-induced nephropathy. Nakazawa Y, Nishino T, Obata Y, Nakazawa M, Furusu A, Abe K, Miyazaki M, Koji T, Kohno S, J Nephrol 2013 26 527 533 10.5301/jn.5000178 22684648
35. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM, J Am Soc Nephrol 2004 15 2115 2124 10.1097/01.ASN.0000135059. 67385.5D 15284297 (Pubitemid 39031350)
36. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. Park SH, Choi MJ, Song IK, Choi SY, Nam JO, Kim CD, Lee BH, Park RW, Park KM, Kim YJ, Kim IS, Kwon TH, Kim YL, J Am Soc Nephrol 2007 18 1497 1507 10.1681/ASN.2005080866 17389738 (Pubitemid 46717516)
37. Treatment of adriamycin-induced nephropathy with erythropoietin and G-CSF. Modelli de Andrade LG, Viero RM, Cordeiro de Carvalho MF, J Nephrol 2013 26 534 539 10.5301/jn.5000200 22972668
38. PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells. Sivertsen EA, Hystad ME, Gutzkow KB, Døsen G, Smeland EB, Blomhoff HK, Myklebust JH, Br J Haematol 2006 135 117 128 10.1111/j.1365-2141.2006.06252.x 16965383 (Pubitemid 44337672)
39. P2X7 receptors mediate deleterious renal epithelial-fibroblast cross talk. Ponnusamy M, Ma L, Gong R, Pang M, Chin YE, Zhuang S, Am J Physiol Renal Physiol 2011 300 62 70 10.1152/ajprenal.00473.2010
40. Mesenchymal stem cells in renal function recovery after acute kidney injury: use of a differentiating agent in a rat model. La Manna G, Bianchi F, Cappuccilli M, Cenacchi G, Tarantino L, Pasquinelli G, Valente S, Della Bella E, Cantoni S, Claudia C, Neri F, Tsivian M, Nardo B, Ventura C, Stefoni S, Cell Transplant 2011 20 1193 1208 10.3727/096368910X543394 21092414
41. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Mias C, Trouche E, Seguelas MH, Calcagno F, Dignat-George F, Sabatier F, Piercecchi-Marti MD, Daniel L, Bianchi P, Calise D, Bourin P, Parini A, Cussac D, Stem Cells 2008 26 1749 1757 10.1634/stemcells. 2007-1000 18467662
42. Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. Esneault E, Pacary E, Eddi D, Freret T, Tixier E, Toutain J, Touzani O, Schumann-Bard P, Petit E, Roussel S, Bernaudin M, J Cereb Blood Flow Metab 2008 28 1552 1563 10.1038/jcbfm.2008.40 18478023